Spruce Biosciences (SPRB) Financials: Revenue & Earnings
SPRB$46.03+0.38 +0.83%
$132.29M
Market Cap
—
P/E
—
Forward P/E
—
Score
Spruce Biosciences (SPRB) Financials: Revenue & Earnings
SPRB price $46.03 +0.38 +0.83%
- Ticker
- SPRB
- Price
- $46.03
- Change
- +0.38 +0.83%
- Market cap ?
- $132.29M
- Beta ?
- 3.30
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
SPRB fair value $35.31. Price $46.03. Price is 30% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -5.68 | — | 50.00M |
| 2026-08-12 | -6.68 | -5.79 | — | — |
| 2026-05-13 | -8.94 | -7.32 | — | — |
| 2026-03-09 | -9.58 | -12.87 | — | 500.00K |
| 2025-11-10 | -14.58 | -15.56 | — | 500.00K |
| 2025-08-15 | -3.50 | -18.00 | — | 500.00K |
| 2025-05-06 | -24.00 | -18.80 | — | 250.00K |
| 2025-04-15 | -42.75 | -0.24 | 700.00K | 885.00K |
| 2024-11-11 | -15.79 | -0.27 | 602.00K | 1.49M |
| 2024-08-12 | -16.54 | -0.33 | 1.61M | 1.50M |
| 2024-05-13 | -21.05 | -21.64 | 2.00M | 1.15M |
| 2024-03-14 | -17.29 | -0.41 | 2.90M | 1.55M |
| 2023-11-13 | -22.50 | -25.56 | 3.07M | 2.25M |
| 2023-08-14 | -0.32 | -0.39 | 2.17M | 980.00K |
| 2023-05-15 | -0.40 | -0.42 | 1.98M | 6.30M |
| 2023-03-16 | -0.47 | -0.53 | — | — |
| 2022-11-10 | -0.48 | -0.54 | — | — |
| 2022-08-10 | -18.75 | -0.53 | — | — |
| 2022-05-11 | -0.50 | -0.46 | — | — |
| 2022-03-14 | -15.00 | -0.54 | — | — |
| 2021-11-15 | -36.84 | -42.86 | — | — |
| 2021-08-10 | -37.59 | -33.83 | — | — |
| 2021-05-12 | -31.58 | -33.08 | — | — |
| 2021-03-22 | -29.32 | -45.11 | — | — |
| 2020-11-18 | -12.35 | -0.51 | — | — |
| 2020-10-09 | -11.25 | — | — | — |
| 2020-03-31 | -8.55 | — | — | — |
| 2019-12-31 | -5.38 | — | — | — |
| 2019-09-30 | -4.23 | — | — | — |
| 2019-06-30 | -185.03 | — | — | — |
| 2019-03-31 | -185.03 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-27 | Quartel Adrian W | Buy | 13.00K | — | — |
| 2026-07-27 | Quartel Adrian W | Other | 0 | — | — |
| 2026-06-30 | Szwarcberg Javier B. | Buy | 266 | $4.53 | 1.21K |
| 2026-05-21 | SPIEGELMAN DANIEL K | Buy | 1.70K | $52.70 | 89.59K |
| 2026-05-21 | SIMPSON CAMILLA V | Buy | 1.70K | $52.70 | 89.59K |
| 2026-05-21 | GREY MICHAEL G | Buy | 1.70K | $52.70 | 89.59K |
| 2026-05-21 | Barretto-Ko Percival | Buy | 1.70K | $52.70 | 89.59K |
| 2026-05-21 | Walbert Keli | Buy | 1.70K | $52.70 | 89.59K |
| 2026-03-09 | Hooks Corwin Dale | Buy | 11.00K | — | — |
| 2026-03-09 | Hooks Corwin Dale | Other | 0 | — | — |
| 2025-12-31 | Szwarcberg Javier B. | Buy | 4.69K | $4.53 | 21.25K |
| 2025-12-15 | Gharib Samir M. | Buy | 513 | — | — |
| 2025-12-15 | Gharib Samir M. | Sell | 184 | $80.67 | 14.84K |
| 2025-12-15 | Gharib Samir M. | Buy | 496 | — | — |
| 2025-12-15 | Gharib Samir M. | Sell | 178 | $80.67 | 14.36K |
| 2025-12-15 | Gharib Samir M. | Sell | 513 | — | — |
| 2025-12-15 | Gharib Samir M. | Sell | 496 | — | — |
| 2025-12-15 | Szwarcberg Javier B. | Buy | 1.20K | — | — |
| 2025-12-15 | Szwarcberg Javier B. | Buy | 1.48K | — | — |
| 2025-12-15 | Szwarcberg Javier B. | Sell | 608 | $80.67 | 49.05K |
| 2025-12-15 | Szwarcberg Javier B. | Sell | 752 | $80.67 | 60.66K |
| 2025-12-15 | Szwarcberg Javier B. | Sell | 1.20K | — | — |
| 2025-12-15 | Szwarcberg Javier B. | Sell | 1.48K | — | — |
| 2025-12-11 | Ways Douglas Kirk | Buy | 5.00K | — | — |
| 2025-12-11 | Ways Douglas Kirk | Sell | 1.25K | — | — |
| 2025-12-11 | Ways Douglas Kirk | Buy | 1.25K | — | — |
| 2025-12-11 | Ways Douglas Kirk | Buy | 400 | $104.13 | 41.65K |
| 2025-12-11 | Ways Douglas Kirk | Buy | 266 | $104.13 | 27.70K |
| 2025-12-11 | Ways Douglas Kirk | Sell | 266 | $791.25 | 210.47K |
| 2025-12-11 | Ways Douglas Kirk | Sell | 400 | $169.50 | 67.80K |
| 2025-12-11 | Szwarcberg Javier B. | Buy | 1.67K | $104.13 | 173.48K |
| 2025-12-11 | SPIEGELMAN DANIEL K | Buy | 458 | $104.13 | 47.69K |
| 2025-12-11 | SPIEGELMAN DANIEL K | Buy | 400 | $104.13 | 41.65K |
| 2025-12-11 | SPIEGELMAN DANIEL K | Buy | 88 | $104.13 | 9.16K |
| 2025-12-11 | SPIEGELMAN DANIEL K | Sell | 88 | $1,143.00 | 100.58K |
| 2025-12-11 | SPIEGELMAN DANIEL K | Sell | 400 | $169.50 | 67.80K |
| 2025-12-11 | SPIEGELMAN DANIEL K | Sell | 458 | $564.00 | 258.31K |
| 2025-12-11 | GREY MICHAEL G | Buy | 1.50K | $104.13 | 156.09K |
| 2025-12-11 | GREY MICHAEL G | Buy | 1.25K | $104.13 | 130.68K |
| 2025-12-11 | GREY MICHAEL G | Buy | 666 | $104.13 | 69.35K |
| 2025-12-11 | GREY MICHAEL G | Buy | 400 | $104.13 | 41.65K |
| 2025-12-11 | GREY MICHAEL G | Buy | 387 | $104.13 | 40.30K |
| 2025-12-11 | GREY MICHAEL G | Buy | 133 | $104.13 | 13.85K |
| 2025-12-11 | GREY MICHAEL G | Sell | 387 | $108.00 | 41.80K |
| 2025-12-11 | GREY MICHAEL G | Sell | 1.25K | $123.00 | 154.37K |
| 2025-12-11 | GREY MICHAEL G | Sell | 1.50K | $230.25 | 345.14K |
| 2025-12-11 | GREY MICHAEL G | Sell | 133 | $1,143.00 | 152.02K |
| 2025-12-11 | GREY MICHAEL G | Sell | 666 | $186.00 | 123.88K |
| 2025-12-11 | GREY MICHAEL G | Sell | 400 | $169.50 | 67.80K |
| 2025-12-11 | Gharib Samir M. | Buy | 1.93K | $104.13 | 201.28K |
| 2025-12-11 | Gharib Samir M. | Buy | 1.58K | $104.13 | 164.42K |
| 2025-12-11 | Gharib Samir M. | Buy | 953 | $104.13 | 99.24K |
| 2025-12-11 | Gharib Samir M. | Buy | 933 | $104.13 | 97.15K |
| 2025-12-11 | Gharib Samir M. | Buy | 733 | $104.13 | 76.33K |
| 2025-12-11 | Gharib Samir M. | Sell | 733 | $1,506.00 | 1.10M |
| 2025-12-11 | Gharib Samir M. | Sell | 1.58K | $123.00 | 194.22K |
| 2025-12-11 | Gharib Samir M. | Sell | 933 | $344.25 | 321.19K |
| 2025-12-11 | Gharib Samir M. | Sell | 1.93K | $186.00 | 359.54K |
| 2025-12-11 | Gharib Samir M. | Sell | 953 | $230.25 | 219.43K |
| 2025-12-11 | Szwarcberg Javier B. | Buy | 10.00K | $104.13 | 1.04M |
| 2025-12-11 | Szwarcberg Javier B. | Sell | 10.00K | $344.25 | 3.44M |
| 2025-12-11 | SIMPSON CAMILLA V | Buy | 400 | $104.13 | 41.65K |
| 2025-12-11 | SIMPSON CAMILLA V | Buy | 362 | $104.13 | 37.70K |
| 2025-12-11 | SIMPSON CAMILLA V | Buy | 309 | $104.13 | 32.18K |
| 2025-12-11 | SIMPSON CAMILLA V | Buy | 173 | $104.13 | 18.01K |
| 2025-12-11 | SIMPSON CAMILLA V | Buy | 133 | $104.13 | 13.85K |
| 2025-12-11 | SIMPSON CAMILLA V | Sell | 362 | $230.25 | 83.35K |
| 2025-12-11 | SIMPSON CAMILLA V | Sell | 400 | $169.50 | 67.80K |
| 2025-12-11 | SIMPSON CAMILLA V | Sell | 133 | $1,143.00 | 152.02K |
| 2025-12-11 | SIMPSON CAMILLA V | Sell | 309 | $123.00 | 38.01K |
| 2025-12-11 | SIMPSON CAMILLA V | Sell | 173 | $108.00 | 18.68K |
| 2025-12-11 | Barretto-Ko Percival | Buy | 800 | $104.13 | 83.30K |
| 2025-12-11 | Barretto-Ko Percival | Sell | 800 | $169.50 | 135.60K |
| 2025-12-11 | Walbert Keli | Buy | 3.40K | $88.41 | 300.59K |
| 2025-12-11 | Walbert Keli | Other | 0 | — | — |
| 2025-12-11 | Gharib Samir M. | Buy | 1.90K | — | — |
| 2025-12-11 | Gharib Samir M. | Sell | 680 | $88.41 | 60.12K |
| 2025-12-11 | Gharib Samir M. | Buy | 7.60K | — | — |
| 2025-12-11 | Gharib Samir M. | Sell | 1.90K | — | — |
| 2025-12-11 | Szwarcberg Javier B. | Buy | 19.80K | — | — |
| 2025-12-11 | Szwarcberg Javier B. | Buy | 4.95K | — | — |
| 2025-12-11 | Szwarcberg Javier B. | Sell | 4.95K | — | — |
| 2025-12-11 | Szwarcberg Javier B. | Sell | 2.19K | $88.41 | 193.97K |
| 2025-12-10 | Gharib Samir M. | Buy | 514 | — | — |
| 2025-12-10 | Gharib Samir M. | Sell | 184 | $85.67 | 15.76K |
| 2025-12-10 | Gharib Samir M. | Sell | 514 | — | — |
| 2025-12-10 | Szwarcberg Javier B. | Buy | 1.20K | — | — |
| 2025-12-10 | Szwarcberg Javier B. | Sell | 428 | $85.67 | 36.67K |
| 2025-12-10 | Szwarcberg Javier B. | Sell | 1.20K | — | — |
| 2025-10-20 | Gharib Samir M. | Buy | 2.05K | — | — |
| 2025-10-20 | Gharib Samir M. | Sell | 661 | $148.16 | 97.93K |
| 2025-10-20 | Gharib Samir M. | Buy | 2.05K | — | — |
| 2025-10-20 | Gharib Samir M. | Sell | 2.05K | — | — |
| 2025-10-20 | Szwarcberg Javier B. | Buy | 4.78K | — | — |
| 2025-10-20 | Szwarcberg Javier B. | Sell | 1.54K | $148.16 | 228.02K |
| 2025-10-20 | Szwarcberg Javier B. | Buy | 4.78K | — | — |
| 2025-10-20 | Szwarcberg Javier B. | Sell | 4.78K | — | — |
| 2025-10-06 | Parkman Healthcare Partners LLC | Buy | 256 | $17.91 | 4.59K |
| 2025-10-06 | Parkman Healthcare Partners LLC | Sell | 232 | $19.33 | 4.48K |
| 2025-10-06 | Parkman Healthcare Partners LLC | Sell | 25 | $17.46 | 436 |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 65, holders +33 vs prior quarter. Ownership 82.76%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | 250.00K | 250.00K | New | 13.50M |
| ORBIMED ADVISORS LLC | 200.00K | 200.00K | New | 10.80M |
| BLACKROCK, INC. | 187.84K | 170.90K | +1008.96% | 10.14M |
| MILLENNIUM MANAGEMENT LLC | 160.98K | 49.09K | +43.88% | 8.69M |
| IKARIAN CAPITAL, LLC | 121.36K | 0 | 0.00% | 6.55M |
| VANGUARD CAPITAL MANAGEMENT LLC | 119.33K | 100.99K | +550.77% | 6.44M |
| ALYESKA INVESTMENT GROUP, L.P. | 81.67K | 30.00K | +58.06% | 4.41M |
| GEODE CAPITAL MANAGEMENT, LLC | 70.55K | 57.66K | +447.35% | 3.81M |
| ADAR1 CAPITAL MANAGEMENT, LLC | 67.72K | 9.12K | +15.56% | 3.66M |
| CABLE CAR CAPITAL, LP | 60.00K | 60.00K | New | 3.24M |
| CITADEL ADVISORS LLC | 51.91K | -18.09K | -25.85% | 2.80M |
| STATE STREET CORP | 50.45K | 45.05K | +834.26% | 2.72M |
| BOOTHBAY FUND MANAGEMENT, LLC | 42.08K | 0 | 0.00% | 2.27M |
| STEMPOINT CAPITAL LP | 41.39K | 35.03K | +550.75% | 2.23M |
| EVERSEPT PARTNERS, LP | 40.00K | 40.00K | New | 2.16M |
| CARLYLE GROUP INC. | 38.62K | 0 | 0.00% | 2.09M |
| GOLDMAN SACHS GROUP INC | 32.35K | 26.84K | +487.50% | 1.75M |
| DIADEMA PARTNERS LP | 30.00K | 20.00K | +200.00% | 1.62M |
| AFFINITY ASSET ADVISORS, LLC | 30.00K | 30.00K | New | 1.62M |
| STONEPINE CAPITAL MANAGEMENT, LLC | 28.80K | 28.80K | New | 1.55M |
| POINT72 ASSET MANAGEMENT, L.P. | 28.28K | 28.28K | New | 1.53M |
| QUINN OPPORTUNITY PARTNERS LLC | 26.81K | 0 | 0.00% | 1.45M |
| UBS GROUP AG | 23.38K | 19.46K | +496.61% | 1.26M |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 22.00K | 0 | 0.00% | 1.19M |
| NORTHERN TRUST CORP | 21.08K | 21.08K | New | 1.14M |
Earnings and financials
Spruce Biosciences, Inc. (SPRB) trades at $46.03, with a market cap of $132.29M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn